HBP1: A HMG box transcriptional repressor that is targeted by the retinoblastoma family

Genes and Development

Volumn 11, Issue 3, 1997, Pages 383-396

  Tevosian, Sergei G ^a,b   Shih, Heather H ^a   Mendelson, Kim G ^a,b   Sheppard, Kelly Ann ^a   Paulson, K Eric ^a,b   Yee, Amy S ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS UNIVERSITY   (United States)

Author keywords

HBP1; HMG transcription factor; retinoblastma family

Indexed keywords

HIGH MOBILITY GROUP PROTEIN; REPRESSOR PROTEIN; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; MAMMAL CELL; MITOSIS INHIBITION; NONHUMAN; ONCOGENE C MYB; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; RETINOBLASTOMA; TRANSCRIPTION REGULATION;

EID: 0242464153     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.11.3.383     Document Type: Article

References (72)

1. Bagchi, S., R. Weinmann, and P. Raychaudhuri. 1991. The retinoblastoma protein copurifies with E2F-I, an E1A-regulated inhibitor of the transcription factor E2F. Cell 65: 1063-1072.
2. Buckingham, M. 1994. Molecular biology of muscle differentiation. Cell 78: 15-21.
3. Buyse, I., G. Shao, and S. Huang. 1995. The retinoblastoma protein binds to RIZ, a zincfinger protein that shares an epitope with the adenovirus E1A protein. Proc. Natl. Acad. Sci. 92: 4467-4471.
4. Carlsson, P., M.L. Waterman, and K.A. Jones. 1993. The hLEF/ TCK-1α HMG protein contains a context-dependent transcriptional activation domain that induced the TCRα enhancer in T cells. Genes & Dev. 7: 2418-2430.
5. Caruso, M., F. Martelli, A. Giordano, and A. Felsani. 1993. Regulation of MyoD gene transcription and protein function by the transforming domains of the adenovirus E1A oncoprotein. Oncogene 8: 267-278.
6. Charron, J., B.A. Malynn, P. Fisher, V. Stewart, L. Jeannotte, S. Goff, E.J. Robertson, and F. Alt. 1992. Embryonic lethality in mice homozygous for a targeted disruption of the N-myc gene. Genes & Dev. 6: 2248-2257.
7. Chellapan, S., S. Hiebert, M. Mudryj, J. Horowitz, and J.R. Nevins. 1991. The E2F transcription factor is a cellular target for the RB protein. Cell 65: 1053-1061.
8. Chittenden, T., D. Livingston, and W.G. Kaelin. 1991. The T/E1A binding domain of the retinoblastoma product can interact selectively with a sequence-specific DNA binding protein. Cell 65: 1073-1082.
9. Clarke, A.R., E.R. Maandag, M. van Roon, M. van der Lugt, M. van der Valk, M.L. Hooper, A. Berns, and H.T. Riele. 1992. Requirement for a functional Rb-1 gene in murine development. Nature 359: 328-330.
10. Cobrinik, D., P. Whyte, D. Peeper, T. Jacks, and R. Weinberg. 1993. Cell cycle-specific association of E2F with the p130 E1A-binding protein. Genes & Dev. 7: 2392-2404.
11. Cobrinik, D., M.H. Lee, G. Hannon, G. Mulligan, R.T. Bronson, N. Dyson, E. Harlow, D. Beach, R.A. Weinberg, and T. Jacks. 1996. Shared role of the pRB-related p130 and p107 protein in limb development. Genes &. Dev. 10: 1633-1644.
12. Defeo-Jones, D., P. Huang, R. Jones, K. Haskell, G. Vuocolo, M. Hanobik, H. Huber, and A. Oliff. 1991. Cloning of cDNAs for cellular proteins that bind to the retinoblastoma gene product. Nature 352: 251-253.
13. Dowdy, S.F., P.W. Hinds, P. Louie, S.I. Reed, and R.A. Weinberg. 1993. Physical interaction of the retinoblastoma protein with D-type cyclins. Cell 73: 499-511.
14. Dunaief, J.L., B.E. Strober, S. Guha, P.A. Khavari, K. Alin, J. Luban, M. Begemann, G. Crabtree, and S. Goff. 1994. The retinoblastoma protein and BRG1 form a a complex and cooperate to induce cell cycle arrest. Cell 79: 119-130.
15. Dynlacht, B., O. Flores, J.A. Lees, and E. Harlow. 1994. Differential regulation of E2F trans-activation by cyclin/cdk2 complexes. Genes & Dev. 8: 1772-1786.
16. Ewen, M., H.K. Sluss, C.J. Sherr, H. Matsuhime, J. Kato, and D.M. Livingston. 1993. Functional interactions of retinoblastoma and D-type cyclins. Cell 73: 487-497.
17. Farnham, P.J. 1996. Transcriptional control of cell growth: The E2F family. Springer Verlag, New York, NY.
18. Field, S.J., F.Y. Tsai, F. Kuo, A.M. Zubiaga, W.G. Kaelin, D.M. Livingston, S.H. Orkin, and M.E. Greenberg. 1996. E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 85: 549-561.
19. Flemington, E.K., S.H. Speck, and W.G. Kaelin. 1993. E2F-1 mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product. Proc. Natl. Acad. Sci 90: 6914-6918.
20. Genderen, C.V., R.M. Okamura, I. Farinas, R.G. Quo, T.G. Parslow, L. Bruhn, and R. Grosschedl. 1994. Development of several organs that require inductive epithelial-mesenchymal interactions is impaired in LEF-1-deficient mice. Genes & Dev. 8: 2691-2703.
21. Giese, K., J. Cox, and R. Grosschedl. 1992. The HMG domain of lymphoid enhancer factor 1 bends DNA and facilitates assembly of functional nucleoprotein structures. Cell 69: 185-195.
22. Giese, K., C. Kingsley, J. Kirshner, and R. Grosschedl. 1995. Assembly and function of a TCR-α enhancer complex is dependent on LEF-1-induced DNA bending and multiple protein-protein interactions. Genes & Dev. 9: 995-1008.
23. Ginsberg, D., G. Vairo, T. Chittenden, Z.H. Xiao, G. Xu, K.L. Wydner, J. DeCaprio, J. Lawrence, and D.M. Livingston. 1994. E2F-4, a new member of the E2F transcription factor family, interacts with p107. Genes & Dev. 8: 2665-2679.
24. Grosschedl, R. 1995. Higher order nucleoprotein complexes in transcription: Analogies with site-specific recombination. Curr. Opin. Cell Biol. 7: 362-370.
25. Gubbay, J., J. Collignon, P. Koopman, B. Capel, A. Economou, A. Munsterberg, N. Vivian, P. Goodfellow, and R. Lovell-Badge. 1990. A gene mapping to the sex-determining region of the mouse y chromosome is a member of a novel family of embryonically expressed genes. Nature 346: 245-250.
26. Hanna-Rose, W. and U. Hansen. 1996. Active repression mechanisms of eukaryotic transcriptional repressors. Trends Genet. 12: 229-234.
27. Hara, E., S. Okamoto, S. Nakada, Y. Taya, S. Sekiya, and K. Oda. 1993. Protein phosphorylation required for the formation of E2F complexes regulates N-myc transcription during differentiation of human embryonal carcinoma cells. Oncogene 8: 1023-1032.
28. Harper, J.W., G. Adami, N. Wei, K. Keyomarski, and S. Elledge. 1993 The p21 CDK-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816.
29. Helin, K. and E. Harlow. 1993. The retinoblastoma protein as a transcriptional repressor. Trends Cell Biol. 3: 43-46.
30. Helin, K., J.A. Lees, M. Vidal, N. Dyson, E. Harlow, and A. Fattaey 1992. A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell 70: 337-350.
31. Hiebert, S.W., M. Blake, J. Azizkhan, and J.R. Nevins. 1991. Role of E2F transcription factor in E1A-mediated trans activation of cellular genes. J. Virol. 65: 3547-3391.
32. Huang, S., E. Shin, K.A. Sheppard, L. Chokoroverty, B. Shan, Y.W. Qian, E.Y. H.P. Lee, and A.S. Yee. 1992. The retinoblastoma protein region required for interaction with the E2F transcription factor includes the T/E1A binding and carboxy-terminal sequences. DNA Cell Biol. 11: 539-548.
33. Jacks, T., E.M. Fazeli, E. Schmitt, R.T. Bronson, M. A. Goodell, and R.A. Weinberg. 1992. Effects of an Rb mutation in mice. Nature 359: 295-300.
34. Jantzen, H.M., U. Strahle, B. Gloss, F. Stewart, W. Schmid, M. Boshart, R. Miksicek, and G. Schutz. 1987. Cooperativity of glucocorticoid response elements located far upstream of the tyrosine aminotransferase gene. Cell 49: 29-38.
35. Johnson, D.G., J.K. Schwarz, W.D. Cress, and J.R. Nevins. 1993. Expression of transcription factor E2F-1 induces quiescent cells to enter S phase. Nature 365: 349-352.
36. Kaelin, W.G., W. Krek, W.R. Sellers, J.A. DeCaprio, F. Ajchanbaum, C.S. Fuchs, T. Chittenden, Y. Li, P.J. Farnham, M.A. Blanar, D.M. Livingston, and E.K. Flemington. 1992. Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell 70: 351-364.
37. Krek, W., M. Ewen, S. Shirodkar, Z. Arany, W. Kaelin, and D. Livingston. 1994. Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase. Cell 78: 161-172.
38. Lee, E.H.Y.P., C.Y. Chang, N. Hu, Y.C.J. Wang, C.C. Lai, K. Herrup, W.H. Lee, and A. Bradley. 1992. Mice deficient for Rb are nonviable and show defects in neurogenesis and hematopoiesis. Nature 359: 288-294.
39. Lee, E.Y.H.P., N. Hu, S.-S.F. Yuan, L. Cox, A. Bradley, W.-H. Lee, and K. Herrup. 1994. Dual roles of the retinoblastoma proteins in cell cycle regulation and neuron differentiation. Genes & Dev. 8: 2008-2021.
40. Lee, M.H., B.O. Williams, G. Mulligan, S. Mukai, R.T. Bronson, N. Dyson, E. Harlow, and T. Jacks. 1996. Targeted disruption of p107: Functional overlap between p107 and Rb. Genes & Dev. 10: 1621-1632.
41. + transport-defective yeast and regulation of HBP1, a new putative HMG transcriptional regulator. Nucleic Acids Res. 22: 3685-3688.
42. Li, Y., C. Graham, S. Lacy, A. Duncan, and P. Whyte. 1993. The adenovirus E1A-associated 130 kD protein is encoded by a member of the retinoblastoma gene family and physically interacts with cyclins A and E. Genes & Dev. 7: 2366-2377.
43. Livingston, D.M., W.G. Kaelin, T. Chittenden, and X. Qin. 1993. Structural and functional contributions to the G1 blocking action of the retinoblastoma protein. Br. J. Cancer 68: 264-268.
44. Love, J.J., X. Li, D.A. Case, K. Giese, R. Grosschedl, and P.E. Wright. 1995. Structural basis for DNA bending by the architectural transcription factor Lef -1. Nature 376: 791-795.
45. Lukas, J., B.O. Petersen, K. Holm, J. Bartek, and K. Helin. 1996. Deregulated expression of E2F family members induces S-phase entry and overcomes p16-INK4-mediated growth suppression. Mol Cell. Biol. 16: 1047-1057.
46. Maione, R., G. Fimia, P. Holman, B. Schaffhausen, and P. Amati. 1994. Retinoblastoma antioncogene is involved in the inhibition of myogenesis by polyomavirus large T antigen. Cell Growth Differ. 5: 231-237.
47. Mizushima, S. and S. Nagata. 1990. pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res. 18: 5322.
48. Moberg, K., M.A. Starz, and J.A. Lees. 1996. E2F-4 switches from p130 to p107 and pRB in response to cell cycle re-entry. Mol. Cell. Biol. 16: 1436-1449.
49. Mudryj, M., S. Hiebert, and J.R. Nevins. 1990. A role for the adenovirus-inducible E2F transcription factor in a proliferation dependent signal transduction pathway. EMBO J. 9: 2179-2184.
50. Olson, E.N. and W.H. Klein. 1994. hHLH factors in muscle development: Dead lines and commitments, what to leave in and what to leave out. Genes & Dev. 8: 1-8.
51. Peterson, C., H. Gordon, Z. Hall, B. Paterson, and H. Blau. 1990. Negative control of the helix-loop-helix family of myogenic regulators in the NFB mutant. Cell 62: 493-502.
52. Qin, X.Q., D.M. Livingston, W.G. Kaelin, and P.D. Adams. 1994. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl. Acad. Sci. 91: 10918-10922.
53. Riley, D.J., E.Y.-H.P. Lee, and W.-H. Lee. 1994. The retinoblastoma protein: More than a tumor suppressor. Annu. Rev. Cell Biol 10: 1-29.
54. Schneider, J.W., W. Gu, L. Zhu, V. Mahdavi, and B. Nadal-Ginard. 1994. Reversal of terminal differentiation mediated by p107 in Rb -/-muscle cells. Science 264: 1467-1470.
55. Sellers, W.R., J.W. Rodgers, and W.G.J. Kaelin. 1995. A potent transrepression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites. Proc. Natl. Acad. Sci. 92: 11544-11548.
56. Shin, E., A. Shin, C. Paulding, B. Schaffhausen, and A.S. Yee. 1995. Multiple changes in E2F transcription factor function occur upon muscle differentiation. Mol. Cell. Biol. 15: 2252-2262.
57. Shin, E., S.G. Tevosian, and A.S. Yee. 1996. The N-terminal region of E2F-1 is required for transcriptional activation of a new class of target promoter. J. Biol Chem. 271: 12261-12268.
58. Singh, P., J. Coe, and W. Hong. 1995. A role for the retinoblastoma protein in potentiating transcriptional activation by the glucocorticoid receptor. Nature 374: 562-565.
59. Slansky, J. and P.J. Farnham. 1996. Introduction to the E2F family: Protein structure and gene regulation. In Transcriptional control of cell growth: The E2F gene family (ed. P.J. Farnham), pp. 1-30. Springer-Verlag, New York, NY.
60. 1 cell state. Mol. Cell Biol. 16: 6965-6976.
61. Smith, R.K., K. Zimmerman, G.D. Yancopoulos, A. Ma, and F.W. Alt. 1992. Transcriptional down-regulation of N-MYC expression during B-cell development. Mol. Cell. Biol. 12: 1578-1584.
62. Stanton, B.R., A. Perkins, L. Tessarollo, D. Sassoon, and L. Parada. 1992. Loss of N-myc function results in embryonic lethality and failure of the epithelial component of the embryo to develop. Genes &. Dev. 6: 2235-2247.
63. Sugiyama, A., Y. Miyagi, Y. Shirasawa, and T. Kuchino. 1991. Different usage of two polyadenylation signals in transcription of the N-Myc gene in rat tumor cells. Oncogene 11: 2027-2032.
64. Tevosian, S., K.E. Paulson, R. Bronson, and A.S. Yee. 1996. Expression of the E2F-1/DP-1 transcription factor during murine development. Cell Growth Differ. 7: 43-52.
65. Wang, C.Y., B. Petryniak, C.B. Thompson, W.G. Kaelin, and J.M. Leiden. 1993. Regulation of the Ets-related transcription factor Elf-1 by binding to the retinoblastoma protein. Science 260: 1330-1335.
66. Wang, J. and K. Walsh. 1996. Resistance to apoptosis conferred by cdk inhibitors in myocyte differentiation. Science 273: 359-361.
67. Webster, K.A., G. Muscat, and L. Kedes. 1998. Adenovirus Ela products suppress myogenic differentiation and inhibit transcription from muscle-specifc promoters. Nature 332: 553-557.
68. Weintraub, H., R. Davis, D. Lockshon, and A. Lassar. 1990 MyoD hinds cooperatively to two sites in a target enhancer sequence: Occupancy of two sites is required for activation. Proc. Natl. Acad. Sci. 87: 5623-5627.
69. Wu, C.L., L. Zukerberg, C. Ngwu, E. Harlow, and J.A. Lees. 1995. In vivo association of E2F and DP family proteins. Mol. Cell. Biol. 15: 2536-2546.
70. Xu, M., K.A. Sheppard, C.Y. Peng, A.S. Yee, and H. Piwnica-Worms. 1994. Cyclin A/CDK2 hinds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation. Mol. Cell. Biol. 14: 8420-8431.
71. Yamasaki, L., T. Jacks, R. Bronson, E. Golliot, E. Harlow, and N. Dyson. 1996. Tumor induction and tissue atrophy in mice lacking E2F-1. Cell 85: 537-548.
72. Zhou, P., C. Byrne, J. Jacobs, and E. Fuchs. 1995. Lymphoid enhancer factor 1 directs hair follicle patterning and epithelial cell fate. Genes & Dev. 9: 570-583.